We next examined the frequency of KRT14 expression in KRT19+ cells in premalignant and malignant breast lesions, such as ductal carcinoma in situ (DCIS; n = 5) and invasive ductal carcinomas (IDC; n = 6). The gene discussed is KRT19; the disease is ductal breast carcinoma in situ.